The 5th World Parkinson Congress (WPC) was held in Kyoto, Japan from June 4– 7, 2019. More than 3,000 people from more than 60 countries attended the meeting. At this meeting, Dr Ronald Melki of the Centre National de la Recherche Scientifique (CNRS) and PD-MitoQUANT PI presented: “What is alpha-synuclein- The biology”. Through Ronald’s talk, PD-MitoQUANT funding was acknowledged.
Dr Ronald Melki, CNRS at WPC 2019
The WPC 2019 hosted an international, interdisciplinary forum showcasing the most important developments in the world of Parkinson’s. As medical advances continue to accelerate, the goal of the WPC is to advance an all-encompassing approach to the treatment of Parkinson’s by bringing together the full spectrum of those who serve the Parkinson’s community. These will include representatives of professional medical and scientific organizations; nurses and rehabilitation professionals; voluntary, lay, and patient services organizations; the pharmaceutical industry; and the research and health services ministries of national governments, and of course people living with Parkinson’s and their care partners.
